speaker-icon

Latest Posts

Partex-Lupin-press-release-illustration

23

Apr 24

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to...
Read More
Partex-NV-announces-collaboration-with-Althea-DRF-Lifesciences

28

Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Author name: Gunjan Bhardwaj

Gunjan Bhardwaj is the founder and CEO of Innoplexus, a leader in AI and analytics as a service for life science industries. With a background at Boston Consulting Group and Ernst & Young, he bridges the worlds of AI, consulting, and life science to drive innovation.

implementing_data_efficiencies

Implementing data efficiencies through AI-powered dashboards

Traditional drug discovery measures stand at the forefront of change with the developments that the pharmaceutical industry’s collaboration with technology has brought in. Several challenges in data collection, handling, and sharing are improved processes through new tools that focus on accelerating the drug development cycle with accurate, almost real-time data. The drug development process includes …

Implementing data efficiencies through AI-powered dashboards Read More »

discovering-covid-19-novel-molecules

How Innoplexus is discovering novel molecules for COVID-19

At Innoplexus, I work with colleagues who have dedicated their lives and careers to drug discovery and life-sciences. They are biologists, physicians, data scientists and software engineers, armed with knowledge and creativity. We have developed AI capabilities that generate novel molecules to cure COVID-19 in a matter of days, with a single GPU. In the …

How Innoplexus is discovering novel molecules for COVID-19 Read More »

lesson-plan-covid-19

Coronavirus: Why governments need a decisive action plan

Traditionally, surgeons-in-training have been instructed to “see one, do one, teach one”.1 Echoed in David Kolb’s experiential learning theory, this teaching method capitalizes on a holistic, multi-linear model of adult development and skill mastery that declares experience to be the keystone of the learning process.2 When it comes to outbreaks of infectious disease, the world should …

Coronavirus: Why governments need a decisive action plan Read More »

Bloomberg-coronavirus

How is Artificial Intelligence helping the battle against the new Coronavirus?

The Outbreak Artificial intelligence (AI) technology continues to find itself at the heart of contemporary healthcare global news including the ongoing Coronavirus (COVID-19) outbreak. On December 31, only a few weeks into the outbreak, a Canadian disease surveillance company, BlueDot, was the first organization using AI to notify its clients in advance that a cluster …

How is Artificial Intelligence helping the battle against the new Coronavirus? Read More »

research-graph

Explore the biggest life sciences research graph

What is OntosightⓇ Explore? OntosightⓇ is a discovery platform that leverages proprietary artificial intelligence technologies to generate continuous insights for life sciences. OntosightⓇ Explore is a module of the platform that enables exploration, identification, and building of various direct and indirect connections between drugs, targets, pathways, and diseases. Evidence-based network assists in the search of potential drugs and …

Explore the biggest life sciences research graph Read More »

ontosight-explore-vision

Find biological associations between ‘never thought before to be linked’ entities

There was a time when science depended on manual efforts by scientists and researchers. Then, came an avalanche of data and with it the impossibility to read, annotate, and analyze hundreds of articles a day and find required connection between relevant entities. It is rather easy to say that a disease can be cured by …

Find biological associations between ‘never thought before to be linked’ entities Read More »

KOL-discovery

KOL discovery, network analysis, & management

What is OntosightⓇ Influence? OntosightⓇ is a discovery platform that leverages proprietary artificial intelligence technologies to generate continuous insights for life sciences. OntosightⓇ Influence is a module of the platform that enables real-time discovery and network analysis of knowledgeable specialists, key opinion leaders (KOLs), and influencers across the entire drug discovery and development value chain, from preclinical to …

KOL discovery, network analysis, & management Read More »

ontosight-influence

Find key opinion leaders and influencers to drive your therapy’s success

Collaboration with key opinion leaders and influencers becomes crucial at various stages of the drug development chain. When a pharmaceutical company begins its research process, it focuses on patient’s unmet needs. Gaining insights on existing standard of care and ongoing therapies, access to expert insights as well as market needs and leveraging knowledge of leaders …

Find key opinion leaders and influencers to drive your therapy’s success Read More »

research-in-life-science

Accelerate your research and discovery in life sciences

What is OntosightⓇ Discover? OntosightⓇ is an end to end search and discovery platform for life sciences. It leverages artificial intelligence and life science ontology build by Innoplexus to generate continuous insights across preclinical and clinical stages of drug development, spanning all major therapeutic areas and indications. OntosightⓇ Discover is a module of the platform that enables real-time …

Accelerate your research and discovery in life sciences Read More »